Loading
Life sciences · Journal article
Updates in Surgery · November 6, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Background Bariatric and metabolic surgery is one of the most effective treatments for severe obesity and type 2 diabetes mellitus (T2DM), promoting metabolic changes beyond weight loss. However, the biochemical determinants of postoperative glycemic response remain incompletely understood. Methods A scoping review was conducted following PRISMA-ScR guidelines. PubMed/MEDLINE and Scopus were searched for studies published between 2016 and 2025 evaluating metabolic and biochemical variables associated with glycemic outcomes after bariatric surgery. Results Twenty-two studies were included, comprising eight randomized controlled trials and fourteen cohort studies. Bariatric surgery was consistently associated with reductions in HbA1c and significant rates of T2DM remission. Improvements in insulin resistance (HOMA-IR), beta-cell function, and incretin response—particularly GLP-1—were associated with better outcomes. Reductions in inflammatory markers, including IL-6, IFN-γ, and TNF-α, were also reported. Conclusion Glycemic improvement after bariatric surgery is associated with complex metabolic interactions involving insulin sensitivity, incretin modulation, and inflammatory changes. These findings support the role of bariatric and metabolic surgery as a metabolic and immunometabolic intervention, although the descriptive design of a scoping review precludes causal inference.